Lowe Brockenbrough & Co Inc
Source: SEC Form 13F · as of Mar 2026Lowe Brockenbrough & Co Inc holds 18 biotech & pharma companies tracked by BioSniper, totaling $91.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$91.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 47,943 | $11.7M |
| MRKMerck & Co., Inc. | 91,627 | $11.0M |
| PMPhilip Morris International Inc | 61,415 | $10.2M |
| AMGNAMGEN INC | 27,005 | $9.5M |
| ELVElevance Health Inc. | 27,008 | $7.9M |
| LLYELI LILLY & Co | 8,328 | $7.7M |
| PFEPFIZER INC | 238,855 | $6.7M |
| ABBVAbbVie Inc. | 30,639 | $6.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 20,474 | $5.5M |
| ABTABBOTT LABORATORIES | 41,139 | $4.2M |
| DGXQuest Diagnostics Incorporated | 14,787 | $2.9M |
| NVSNovartis AG | 13,766 | $2.1M |
| BMYBRISTOL MYERS SQUIBB CO | 32,835 | $2.0M |
| CORCencora Inc. | 3,359 | $1.1M |
| NVONovo Nordisk A/S | 26,886 | $988K |
| GILDGILEAD SCIENCES, INC. | 6,162 | $859K |
| ZBHZimmer Biomet Holdings Inc. | 6,960 | $629K |
| CAHCardinal Health Inc. | 1,473 | $311K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.